Wealthsource Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Wealthsource Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $2,549 - $2,907	9 Added 0.87%	1,049 $330,000
Q4 2022 Feb 09, 2023	SELL	$285.76 - $321.48 $11,716 - $13,180	-41 Reduced 3.79%	1,040 $300,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $98,304 - $109,685	359 Added 49.72%	1,081 $313,000
Q2 2022 Aug 10, 2022	BUY	$234.96 - $292.55 $169,641 - $211,221	722 New	722 $203,000

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Wealthsource Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthsource Partners, LLC with notifications on news.